Her primary areas of study are Pathology, Breast cancer, Cancer research, Internal medicine and Oncology. Anne Vincent-Salomon has researched Pathology in several fields, including Cancer, Estrogen receptor and Mammary gland. Her Breast cancer research is multidisciplinary, incorporating elements of Radiation therapy, Metastasis and Chemotherapy.
Her Cancer research research integrates issues from Epithelial–mesenchymal transition, Molecular biology, Cellular differentiation and PTEN. Her Internal medicine research focuses on Surgery and how it relates to Clinical trial, Lapatinib and Everolimus. Her studies deal with areas such as Survival rate, Prospective cohort study, Ovarian cancer and Genotype as well as Oncology.
Anne Vincent-Salomon mainly investigates Breast cancer, Internal medicine, Cancer research, Pathology and Oncology. Her Breast cancer study is associated with Cancer. Her biological study spans a wide range of topics, including Gastroenterology and Surgery.
Her Cancer research research is multidisciplinary, incorporating perspectives in Carcinogenesis, Gene, Transcriptome, Immunology and PTEN. Her Pathology study integrates concerns from other disciplines, such as Ductal carcinoma, Comparative genomic hybridization and Mammary gland. Her Oncology research integrates issues from Neoadjuvant therapy, Metastatic breast cancer, Retrospective cohort study, Targeted therapy and Radiation therapy.
Her primary scientific interests are in Breast cancer, Cancer research, Internal medicine, Oncology and Cancer. She has researched Breast cancer in several fields, including Lymph node and Pathology. Her research in Pathology is mostly focused on Carcinoma.
Her Cancer research research includes themes of Cellular differentiation, Transcriptome, Metastasis, Exon and PTEN. The Oncology study combines topics in areas such as Neoadjuvant therapy, Breast surgery, Tumor-infiltrating lymphocytes and Docetaxel. Her Cancer study frequently draws connections between adjacent fields such as Fibroblast.
Breast cancer, Cancer research, Oncology, Internal medicine and Cancer are her primary areas of study. Her research in Breast cancer intersects with topics in GATA3, Gene and Mucinous carcinoma. Anne Vincent-Salomon has included themes like Cellular differentiation, Transcriptome, PI3K/AKT/mTOR pathway, PTEN and Flow cytometry in her Cancer research study.
Her Oncology study combines topics in areas such as Progesterone receptor, Estrogen Receptor Status, Breast carcinoma and Tumor-infiltrating lymphocytes. Internal medicine is closely attributed to Pathology in her study. Her Cancer study combines topics from a wide range of disciplines, such as Regulator and Fibroblast.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Signatures of mutational processes in human cancer
Ludmil B. Alexandrov;Serena Nik-Zainal;Serena Nik-Zainal;David C. Wedge;Samuel A. J. R. Aparicio.
International network of cancer genome projects
Thomas J. Hudson;Thomas J. Hudson;Warwick Anderson;Axel Aretz;Anna D. Barker.
Mutational Processes Molding the Genomes of 21 Breast Cancers
Serena Nik-Zainal;Ludmil B. Alexandrov;David C. Wedge;Peter Van Loo;Peter Van Loo;Peter Van Loo.
The landscape of cancer genes and mutational processes in breast cancer
Philip J. Stephens;Patrick S. Tarpey;Helen Davies;Peter Van Loo;Peter Van Loo.
Landscape of somatic mutations in 560 breast cancer whole-genome sequences
Serena Nik-Zainal;Serena Nik-Zainal;Helen Davies;Johan Staaf;Manasa Ramakrishna.
A pooled analysis of bone marrow micrometastasis in breast cancer
Stephan Braun;Florian D. Vogl;Bjørn Naume;Wolfgang Janni.
The New England Journal of Medicine (2005)
The Life History of 21 Breast Cancers
Serena Nik-Zainal;Peter Van Loo;Peter Van Loo;Peter Van Loo;David C. Wedge;Ludmil B. Alexandrov.
Pan-cancer analysis of whole genomes
Peter J. Campbell;Gad Getz;Jan O. Korbel;Joshua M. Stuart.
Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial
Christophe Le Tourneau;Christophe Le Tourneau;Jean Pierre Delord;Anthony Gonçalves;Céline Gavoille.
Lancet Oncology (2015)
Fibroblast Heterogeneity and Immunosuppressive Environment in Human Breast Cancer
Ana Costa;Ana Costa;Yann Kieffer;Yann Kieffer;Alix Scholer-Dahirel;Alix Scholer-Dahirel;Floriane Pelon;Floriane Pelon.
Cancer Cell (2018)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: